RxDoctor Payments Data

Paul Klein, DPM

Primary Podiatric Medicine · Wayne, NJNPI 1649348947

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,440 of the $5,518 with a category attached, or 80.5%. It is spread thinly across 29 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among primary podiatric medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,518in general payments, 2019–2025

Across 74 payments — averaging $74.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arteriocyte Medical Systems, Inc.$1K
  • Smith+Nephew$635
  • Integra Lifesciences Corporation$433
  • Treace Medical Concepts, Inc.$406
  • Zimmer Biomet$300
  • Organogenesis Inc.$285
  • plus $2K from 23 others
$5,465in research payments, 2019–2025

Across 8 payments — averaging $683.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Axogen$5K

What the payments were for

  • Travel & lodging$1,07820%
  • Food & beverage$4,44080%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,518 in reported general payments places this provider in the 95th percentile of 45 primary podiatric medicine providers in New Jersey.

See all primary podiatric medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$82,202
Medicare patients
164
Services billed
1,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate91$1,955
Ciclopirox27$926
Betamethasone Dipropionate12$401
Clotrimazole29$301

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →